Return to content in this issue

 

Anaphylaxis to Mepolizumab and Omalizumab in a Single Patient: Is Polysorbate the Culprit?

Bergmann KC, Maurer M, Church MK, Zuberbier T

Department of Dermatology and Allergy, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany

J Investig Allergol Clin Immunol 2020; Vol 30(4) : 285-287
doi: 10.18176/jiaci.0492

Key words: Anaphylaxis, Asthma, Mepolizumab, Omalizumab